Carl Zeiss has finally reached an agreement with Asclepion-Meditec over...
Carl Zeiss has finally reached an agreement with Asclepion-Meditec over the valuation of their respective activities, which has been contested by some shareholders. Zeiss will end up owning 76 percent of the new company that will combine its own ophthalmic business with Asclepion, provided the deal is approved at the ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.